Medical Condition

glaucoma

Total Trials

14

Recruiting Now

14

Trial Phases

Phase 4, EARLY_Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for glaucoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — glaucoma Clinical Trials

How many clinical trials are currently recruiting for glaucoma?

ClinicalMetric currently tracks 14 actively recruiting clinical trials for glaucoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for glaucoma?

glaucoma research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a glaucoma clinical trial?

Eligibility criteria for glaucoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 4

Top Sponsors

Assiut University 1 trial

University of Miami 1 trial

Medical University of Vienna 1 trial

Johns Hopkins University 1 trial

Oregon Health and Science University 1 trial

Recruiting Clinical Trials

NCT07455786

Recruiting

Modified Trabeculectomy After Failure of Combined Phaco With GATT

Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma

Medical University of Vienna

View Trial →

NCT07425535 EARLY_Phase 1

Recruiting

Optic Nerve Head Strain in Non-glaucoma Subjects

Johns Hopkins University

View Trial →

NCT01957267

Recruiting

Functional and Structural Imaging for Glaucoma

Oregon Health and Science Univ...

View Trial →

NCT06760169

Recruiting

Efficacy and Safety of the ELIOS Laser in Combined Cataract and Glaucoma Surgery

Hôpital Privé de la Baie

View Trial →

NCT07149740

Recruiting

Data Gathering for A10900

NorMIGS - a Study of Micro-invasive Glaucoma Surgery

Oslo University Hospital

View Trial →

NCT07755761

Recruiting

Innovative Tube Trabeculectomy for Advanced and Refractory Glaucoma: A Randomized Controlled Trial

Efficacy of Biofeedback Training for Glaucoma

University Health Network, Tor...

View Trial →

NCT07243665

Recruiting

Glaucoma Screening Using Artificial Intelligence Assisted Clinical Model in Singapore's Diabetic Eye Screening Program

Singapore Eye Research Institu...

View Trial →

NCT06993597

Recruiting

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

University of Maryland, Baltim...

View Trial →

NCT06854198

Recruiting

Glaucoma Screening to Enhance At-Risk Californians' Health

University of California, San ...

View Trial →

NCT05426044 Phase 2

Recruiting

Metformin as a Neuroprotective Therapy for Glaucoma

Christopher Kai Shun Leung

View Trial →

Related Conditions

open angle glaucoma (1) ocular hypertension (1) glaucoma suspect (1) retinal disease (1) healthy (1) corneal diseases (1) trabeculectomy (1) innovative procedures (1) biofeedback training (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology